Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for INSM

Stock Name	Insmed Inc
Ticker	INSM(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US4576693075
LEI	529900Q55QAG41CCAC11

Show aggregate INSM holdings

News associated with INSM

Analysts Set Insmed, Inc. (NASDAQ:INSM) Price Target at $139.86: Insmed, Inc. (NASDAQ:INSM – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seventeen brokerages that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and sixteen have assigned a buy recommendation to the company. The average 1-year target price among brokerages […] - 2025-09-17 02:58:45
Insmed (NASDAQ:INSM) Reaches New 12-Month High on Analyst Upgrade: Shares of Insmed, Inc. (NASDAQ:INSM – Get Free Report) hit a new 52-week high on Monday after Guggenheim raised their price target on the stock from $125.00 to $172.00. Guggenheim currently has a buy rating on the stock. Insmed traded as high as $146.91 and last traded at $145.86, with a volume of 288114 shares […] - 2025-09-10 02:26:50
Top Analyst Reports for Microsoft, Amazon.com & Philip Morris: Microsoft, Amazon.com and Philip Morris headline fresh analyst reports highlighting AI, cloud, and smoke-free growth momentum. - 2025-09-05 18:11:00
Notable ETF Outflow Detected - XBI, ALNY, HALO, INSM: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $119.6 million dollar outflow -- that's a 2.2% decrease week over week - 2025-08-28 11:56:11
Insmed (NASDAQ:INSM) Earns Outperform Rating from Analysts at William Blair: Stock analysts at William Blair initiated coverage on shares of Insmed (NASDAQ:INSM – Get Free Report) in a research note issued on Wednesday, MarketBeat Ratings reports. The firm set an “outperform” rating on the biopharmaceutical company’s stock. Other research analysts also recently issued reports about the stock. Truist Financial upped their target price on shares […] - 2025-08-22 02:54:45
IMCB's Underlying Holdings Could Mean 12% Gain Potential: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-18 09:44:41
The Goldman Sachs Group Forecasts Strong Price Appreciation for Insmed (NASDAQ:INSM) Stock: Insmed (NASDAQ:INSM – Get Free Report) had its target price increased by equities researchers at The Goldman Sachs Group from $114.00 to $142.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. The Goldman Sachs Group’s price target indicates a potential upside […] - 2025-08-15 07:10:57
INSM Crosses Above Average Analyst Target: In recent trading, shares of Insmed Inc (Symbol: INSM) have crossed above the average analyst 12-month target price of $119.12, changing hands for $122.00/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuati - 2025-08-13 10:41:52
Insmed (NASDAQ:INSM) Reaches New 1-Year High Following Analyst Upgrade: Insmed, Inc. (NASDAQ:INSM – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Monday after Wells Fargo & Company raised their price target on the stock from $119.00 to $130.00. Wells Fargo & Company currently has an overweight rating on the stock. Insmed traded as high as $113.41 and last […] - 2025-08-13 02:23:00
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Insmed, Inc. (NASDAQ:INSM) Shares Purchased by Charles Schwab Investment Management Inc.: Charles Schwab Investment Management Inc. raised its stake in shares of Insmed, Inc. (NASDAQ:INSM – Free Report) by 3.6% during the 1st quarter, Holdings Channel reports. The institutional investor owned 1,602,655 shares of the biopharmaceutical company’s stock after buying an additional 56,048 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Insmed were […] - 2025-08-12 05:59:02
Mackenzie Financial Corp Acquires 2,220 Shares of Insmed, Inc. (NASDAQ:INSM): Mackenzie Financial Corp lifted its holdings in Insmed, Inc. (NASDAQ:INSM – Free Report) by 20.4% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 13,103 shares of the biopharmaceutical company’s stock after buying an additional 2,220 shares during the quarter. Mackenzie Financial Corp’s holdings in […] - 2025-08-06 05:07:44
Insmed, Inc. (NASDAQ:INSM) Shares Acquired by Cwm LLC: Cwm LLC grew its holdings in Insmed, Inc. (NASDAQ:INSM – Free Report) by 24.5% in the 1st quarter, HoldingsChannel.com reports. The fund owned 2,052 shares of the biopharmaceutical company’s stock after buying an additional 404 shares during the quarter. Cwm LLC’s holdings in Insmed were worth $157,000 as of its most recent SEC filing. Several […] - 2025-07-29 04:28:55
Allianz Asset Management GmbH Has $5.74 Million Holdings in Insmed, Inc. (NASDAQ:INSM): Allianz Asset Management GmbH raised its stake in shares of Insmed, Inc. (NASDAQ:INSM – Free Report) by 4.9% in the first quarter, Holdings Channel.com reports. The firm owned 75,284 shares of the biopharmaceutical company’s stock after buying an additional 3,534 shares during the period. Allianz Asset Management GmbH’s holdings in Insmed were worth $5,743,000 as […] - 2025-07-28 05:46:50
Congress Trade: Representative Josh Gottheimer Just Disclosed New Stock Trades: Representative Josh Gottheimer just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Josh Gottheimer and other politicians. - 2025-07-17 10:12:46
Insmed, Inc. (NASDAQ:INSM) Shares Bought by Xponance Inc.: Xponance Inc. boosted its stake in shares of Insmed, Inc. (NASDAQ:INSM – Free Report) by 5.3% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 13,359 shares of the biopharmaceutical company’s stock after buying an additional 670 shares during the period. Xponance Inc.’s holdings in Insmed […] - 2025-07-17 06:35:03
Envestnet Asset Management Inc. Grows Holdings in Insmed, Inc. (NASDAQ:INSM): Envestnet Asset Management Inc. raised its position in Insmed, Inc. (NASDAQ:INSM – Free Report) by 26.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 325,307 shares of the biopharmaceutical company’s stock after purchasing an additional 68,949 shares during the quarter. Envestnet Asset Management […] - 2025-07-16 07:23:19
Sara Bonstein Sells 57,764 Shares of Insmed, Inc. (NASDAQ:INSM) Stock: Insmed, Inc. (NASDAQ:INSM – Get Free Report) CFO Sara Bonstein sold 57,764 shares of the company’s stock in a transaction on Monday, July 7th. The shares were sold at an average price of $95.86, for a total value of $5,537,257.04. Following the completion of the sale, the chief financial officer owned 84,017 shares in the […] - 2025-07-11 05:13:00
Teacher Retirement System of Texas Sells 2,654 Shares of Insmed, Inc. (NASDAQ:INSM): Teacher Retirement System of Texas lessened its holdings in shares of Insmed, Inc. (NASDAQ:INSM – Free Report) by 5.5% during the 1st quarter, Holdings Channel.com reports. The firm owned 45,683 shares of the biopharmaceutical company’s stock after selling 2,654 shares during the period. Teacher Retirement System of Texas’ holdings in Insmed were worth $3,485,000 at […] - 2025-07-09 05:48:57
Brokerages Set Insmed, Inc. (NASDAQ:INSM) Target Price at $106.80: Shares of Insmed, Inc. (NASDAQ:INSM – Get Free Report) have earned an average rating of “Buy” from the seventeen brokerages that are presently covering the stock, MarketBeat Ratings reports. Seventeen equities research analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have updated their coverage on the […] - 2025-07-04 02:40:47
Insmed, Inc. (NASDAQ:INSM) CFO Sara Bonstein Sells 57,765 Shares: Insmed, Inc. (NASDAQ:INSM – Get Free Report) CFO Sara Bonstein sold 57,765 shares of the stock in a transaction on Monday, June 23rd. The shares were sold at an average price of $101.78, for a total value of $5,879,321.70. Following the completion of the sale, the chief financial officer now owns 93,536 shares in the […] - 2025-06-27 05:06:55
Avior Wealth Management LLC Raises Holdings in Insmed, Inc. (NASDAQ:INSM): Avior Wealth Management LLC lifted its holdings in shares of Insmed, Inc. (NASDAQ:INSM – Free Report) by 82.2% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 4,151 shares of the biopharmaceutical company’s stock after acquiring an additional 1,873 shares during the period. Avior Wealth Management LLC’s holdings […] - 2025-06-23 05:12:58
Is Insmed Stock Overvalued at $98?: Insmed Inc (NASDAQ: INSM) was nothing short of a juggernaut last month, skyrocketing 45%, while the S&P500 index gained 3% during the same period. What’s fueling the fire? Insmed announced that its Phase IIb trial for treprostinil palmitil inhalation powder (TPIP) in pulmonar - 2025-06-17 03:35:22
Notable ETF Outflow Detected - IWO, SFM, INSM, FTAI: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 2000 Growth ETF (Symbol: IWO) where we have detected an approximate $123.7 million dollar outflow -- that's a 1.1% decrease week ove - 2025-06-16 11:49:52
Insmed Incorporated (NASDAQ:INSM) CFO Sells $5,148,105.92 in Stock: Insmed Incorporated (NASDAQ:INSM – Get Free Report) CFO Sara Bonstein sold 57,766 shares of the company’s stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $89.12, for a total transaction of $5,148,105.92. Following the sale, the chief financial officer now directly owns 103,412 shares in the company, […] - 2025-06-16 05:18:57
Park Avenue Securities LLC Has $842,000 Holdings in Insmed Incorporated (NASDAQ:INSM): Park Avenue Securities LLC boosted its position in shares of Insmed Incorporated (NASDAQ:INSM – Free Report) by 38.7% during the 1st quarter, Holdings Channel reports. The institutional investor owned 11,036 shares of the biopharmaceutical company’s stock after purchasing an additional 3,081 shares during the quarter. Park Avenue Securities LLC’s holdings in Insmed were worth $842,000 […] - 2025-06-13 05:18:50
Morgan Stanley Increases Insmed (NASDAQ:INSM) Price Target to $102.00: Insmed (NASDAQ:INSM – Get Free Report) had its price objective lifted by stock analysts at Morgan Stanley from $90.00 to $102.00 in a report released on Wednesday,Benzinga reports. The firm currently has an “overweight” rating on the biopharmaceutical company’s stock. Morgan Stanley’s target price suggests a potential upside of 5.28% from the stock’s previous close. […] - 2025-06-13 04:40:52
Insmed (NASDAQ:INSM) Stock Price Expected to Rise, Royal Bank of Canada Analyst Says: Insmed (NASDAQ:INSM – Get Free Report) had its target price raised by research analysts at Royal Bank of Canada from $99.00 to $106.00 in a report issued on Wednesday,Benzinga reports. The brokerage presently has an “outperform” rating on the biopharmaceutical company’s stock. Royal Bank of Canada’s price target would suggest a potential upside of 9.41% […] - 2025-06-13 04:40:51
Insmed (NASDAQ:INSM) Stock Price Expected to Rise, Mizuho Analyst Says: Insmed (NASDAQ:INSM – Get Free Report) had its price objective lifted by equities research analysts at Mizuho from $96.00 to $110.00 in a report issued on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the biopharmaceutical company’s stock. Mizuho’s price target points to a potential upside of 13.54% from the company’s current price. […] - 2025-06-13 04:40:49
Insmed (NASDAQ:INSM) Shares Up 4.5% Following Analyst Upgrade: Insmed Incorporated (NASDAQ:INSM – Get Free Report)’s stock price traded up 4.5% during trading on Wednesday after The Goldman Sachs Group raised their price target on the stock from $100.00 to $112.00. The Goldman Sachs Group currently has a buy rating on the stock. Insmed traded as high as $93.82 and last traded at $95.02. […] - 2025-06-13 02:17:01

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) INSM holdings

Date	Number of INSM Shares Held	Base Market Value of INSM Shares	Local Market Value of INSM Shares	Change in INSM Shares Held	Change in INSM Base Value	Current Price per INSM Share Held	Previous Price per INSM Share Held
2025-12-03 (Wednesday)	148,472	USD 30,701,040	USD 30,701,040	250	USD 78,375	USD 206.78	USD 206.6
2025-12-02 (Tuesday)	148,222	USD 30,622,665	USD 30,622,665	5,265	USD 400,126	USD 206.6	USD 211.41
2025-12-01 (Monday)	142,957	USD 30,222,539	USD 30,222,539	0	USD 520,363	USD 211.41	USD 207.77
2025-11-28 (Friday)	142,957	USD 29,702,176	USD 29,702,176	351	USD 537,823	USD 207.77	USD 204.51
2025-11-27 (Thursday)	142,606	USD 29,164,353	USD 29,164,353	0	USD 0	USD 204.51	USD 204.51
2025-11-26 (Wednesday)	142,606	USD 29,164,353	USD 29,164,353	1,053	USD -423,055	USD 204.51	USD 209.02
2025-11-25 (Tuesday)	141,553	USD 29,587,408	USD 29,587,408	1,755	USD 659,008	USD 209.02	USD 206.93
2025-11-24 (Monday)	139,798	USD 28,928,400	USD 28,928,400	351	USD 1,211,914	USD 206.93	USD 198.76
2025-11-21 (Friday)	139,447	USD 27,716,486	USD 27,716,486	0	USD -122,713	USD 198.76	USD 199.64
2025-11-20 (Thursday)	139,447	USD 27,839,199	USD 27,839,199	-1,404	USD -832,431	USD 199.64	USD 203.56
2025-11-19 (Wednesday)	140,851	USD 28,671,630	USD 28,671,630	351	USD 344,020	USD 203.56	USD 201.62
2025-11-18 (Tuesday)	140,500	USD 28,327,610	USD 28,327,610	2,106	USD 1,008,634	USD 201.62	USD 197.4
2025-11-17 (Monday)	138,394	USD 27,318,976	USD 27,318,976	702	USD 714,128	USD 197.4	USD 193.22

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of INSM by Blackrock for IE00BDZVHG35

Show aggregate share trades of INSM

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-03 BUY 250 207.605 203.330 203.758 USD 50,939 99.90
2025-12-02 BUY 5,265 212.750 206.100 206.765 USD 1,088,618 99.37
2025-11-28 BUY 351 208.050 202.880 203.397 USD 71,392 98.27
2025-11-26 BUY 1,053 209.000 202.270 202.943 USD 213,699 97.20
2025-11-26 BUY 1,053 209.000 202.270 202.943 USD 213,699 97.20
2025-11-25 BUY 1,755 209.770 205.230 205.684 USD 360,975 96.63
2025-11-24 BUY 351 208.720 199.520 200.440 USD 70,354 96.07
2025-11-20 SELL -1,404 207.990 199.000 199.899 USD -280,658 95.00 Loss of -147,274 on sale
2025-11-19 BUY 351 205.110 200.190 200.682 USD 70,439 94.44
2025-11-18 BUY 2,106 203.650 195.510 196.324 USD 413,458 93.88
2025-11-17 BUY 702 197.880 191.825 192.430 USD 135,086 93.34
2025-11-14 BUY 351 197.445 187.550 188.540 USD 66,177 92.81
2025-11-12 BUY 351 196.330 191.940 192.379 USD 67,525 91.75
2025-11-10 BUY 350 192.390 185.690 186.360 USD 65,226 90.67
2025-11-06 BUY 350 188.440 183.810 184.273 USD 64,496 89.61
2025-11-04 BUY 351 187.880 182.580 183.110 USD 64,272 88.56
2025-10-30 BUY 1,755 194.700 167.000 169.770 USD 297,947 86.86
2025-10-29 BUY 1,015 166.950 167.780 167.697 USD 170,212 86.41
2025-10-22 SELL -1,404 160.400 166.620 165.998 USD -233,061 84.23 Loss of -114,798 on sale
2025-10-20 BUY 702 167.910 168.220 168.189 USD 118,069 83.27
2025-10-17 BUY 1,753 165.760 166.040 166.012 USD 291,019 82.78
2025-10-15 BUY 2,792 163.540 165.760 165.538 USD 462,182 82.31
2025-10-03 BUY 2,429 157.160 158.190 158.087 USD 383,993 81.38
2025-10-02 BUY 347 152.800 152.850 152.845 USD 53,037 80.95
2025-09-30 BUY 694 144.010 145.410 145.270 USD 100,817 80.17
2025-09-26 BUY 694 137.030 137.040 137.039 USD 95,105 79.44
2025-09-25 BUY 694 135.590 140.650 140.144 USD 97,260 79.09
2025-09-18 BUY 314 145.860 146.500 146.436 USD 45,981 78.67
2025-09-17 BUY 948 144.780 146.500 146.328 USD 138,719 78.25
2025-07-17 SELL -630 104.170 105.350 105.232 USD -66,296 77.34 Loss of -17,571 on sale
2025-07-16 BUY 1,096 104.590 105.080 105.031 USD 115,114 77.16
2025-07-11 SELL -2,488 98.180 99.390 99.269 USD -246,981 76.69 Loss of -56,172 on sale
2025-07-02 BUY 17,105 98.240 98.380 98.366 USD 1,682,550 76.13
2025-06-25 BUY 622 104.850 106.830 106.632 USD 66,325 75.42
2025-06-20 BUY 2,924 102.680 102.810 102.797 USD 300,578 74.79
2025-06-13 BUY 282 98.730 99.650 99.558 USD 28,075 73.86
2025-06-11 BUY 1,200 97.980 98.950 98.853 USD 118,624 73.51
2025-06-04 SELL -300 73.690 74.560 74.473 USD -22,342 73.39 Loss of -323 on sale
2025-04-23 BUY 300 70.800 72.710 72.519 USD 21,756 74.81
2025-04-10 SELL -2,400 64.810 67.190 66.952 USD -160,685 75.28 Profit of 19,979 on sale
2025-04-08 SELL -300 64.970 70.560 70.001 USD -21,000 75.48 Profit of 1,645 on sale
2025-04-07 SELL -300 68.090 70.520 70.277 USD -21,083 75.57 Profit of 1,588 on sale
2025-04-04 SELL -1,500 69.180 72.500 72.168 USD -108,252 75.64 Profit of 5,215 on sale
2025-04-01 BUY 2,597 72.000 75.650 75.285 USD 195,515 75.72
2025-03-31 SELL -888 76.290 76.700 76.659 USD -68,073 75.71 Loss of -844 on sale
2025-03-21 BUY 4,857 79.920 81.190 81.063 USD 393,723 75.50
2025-03-14 SELL -4,480 76.550 77.410 77.324 USD -346,412 75.34 Loss of -8,899 on sale
2025-03-07 SELL -558 74.890 76.170 76.042 USD -42,431 75.43 Loss of -343 on sale
2025-03-04 SELL -280 77.210 78.410 78.290 USD -21,921 75.37 Loss of -817 on sale
2025-02-25 BUY 560 77.500 81.670 81.253 USD 45,502 75.10
2025-02-19 SELL -279 83.830 83.890 83.884 USD -23,404 74.58 Loss of -2,595 on sale
2025-02-13 BUY 837 78.670 79.690 79.588 USD 66,615 74.17
2025-02-12 BUY 279 79.600 80.280 80.212 USD 22,379 74.06
2025-02-11 BUY 1,116 79.890 80.010 79.998 USD 89,278 73.94
2024-12-30 SELL -6,129 68.870 69.600 69.527 USD -426,131 72.36 Profit of 17,381 on sale
2024-11-18 SELL -4,425 66.610 67.260 67.195 USD -297,338 70.94 Profit of 16,559 on sale
2024-11-08 SELL -295 73.540 73.640 73.630 USD -21,721 70.81 Loss of -832 on sale
2024-10-21 SELL -295 72.280 74.290 74.089 USD -21,856 0.00 Loss of -21,856 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-03	BUY	250	207.605	203.330	203.758	USD 50,939	99.90
2025-12-02	BUY	5,265	212.750	206.100	206.765	USD 1,088,618	99.37
2025-11-28	BUY	351	208.050	202.880	203.397	USD 71,392	98.27
2025-11-26	BUY	1,053	209.000	202.270	202.943	USD 213,699	97.20
2025-11-26	BUY	1,053	209.000	202.270	202.943	USD 213,699	97.20
2025-11-25	BUY	1,755	209.770	205.230	205.684	USD 360,975	96.63
2025-11-24	BUY	351	208.720	199.520	200.440	USD 70,354	96.07
2025-11-20	SELL	-1,404	207.990	199.000	199.899	USD -280,658	95.00 Loss of -147,274 on sale
2025-11-19	BUY	351	205.110	200.190	200.682	USD 70,439	94.44
2025-11-18	BUY	2,106	203.650	195.510	196.324	USD 413,458	93.88
2025-11-17	BUY	702	197.880	191.825	192.430	USD 135,086	93.34
2025-11-14	BUY	351	197.445	187.550	188.540	USD 66,177	92.81
2025-11-12	BUY	351	196.330	191.940	192.379	USD 67,525	91.75
2025-11-10	BUY	350	192.390	185.690	186.360	USD 65,226	90.67
2025-11-06	BUY	350	188.440	183.810	184.273	USD 64,496	89.61
2025-11-04	BUY	351	187.880	182.580	183.110	USD 64,272	88.56
2025-10-30	BUY	1,755	194.700	167.000	169.770	USD 297,947	86.86
2025-10-29	BUY	1,015	166.950	167.780	167.697	USD 170,212	86.41
2025-10-22	SELL	-1,404	160.400	166.620	165.998	USD -233,061	84.23 Loss of -114,798 on sale
2025-10-20	BUY	702	167.910	168.220	168.189	USD 118,069	83.27
2025-10-17	BUY	1,753	165.760	166.040	166.012	USD 291,019	82.78
2025-10-15	BUY	2,792	163.540	165.760	165.538	USD 462,182	82.31
2025-10-03	BUY	2,429	157.160	158.190	158.087	USD 383,993	81.38
2025-10-02	BUY	347	152.800	152.850	152.845	USD 53,037	80.95
2025-09-30	BUY	694	144.010	145.410	145.270	USD 100,817	80.17
2025-09-26	BUY	694	137.030	137.040	137.039	USD 95,105	79.44
2025-09-25	BUY	694	135.590	140.650	140.144	USD 97,260	79.09
2025-09-18	BUY	314	145.860	146.500	146.436	USD 45,981	78.67
2025-09-17	BUY	948	144.780	146.500	146.328	USD 138,719	78.25
2025-07-17	SELL	-630	104.170	105.350	105.232	USD -66,296	77.34 Loss of -17,571 on sale
2025-07-16	BUY	1,096	104.590	105.080	105.031	USD 115,114	77.16
2025-07-11	SELL	-2,488	98.180	99.390	99.269	USD -246,981	76.69 Loss of -56,172 on sale
2025-07-02	BUY	17,105	98.240	98.380	98.366	USD 1,682,550	76.13
2025-06-25	BUY	622	104.850	106.830	106.632	USD 66,325	75.42
2025-06-20	BUY	2,924	102.680	102.810	102.797	USD 300,578	74.79
2025-06-13	BUY	282	98.730	99.650	99.558	USD 28,075	73.86
2025-06-11	BUY	1,200	97.980	98.950	98.853	USD 118,624	73.51
2025-06-04	SELL	-300	73.690	74.560	74.473	USD -22,342	73.39 Loss of -323 on sale
2025-04-23	BUY	300	70.800	72.710	72.519	USD 21,756	74.81
2025-04-10	SELL	-2,400	64.810	67.190	66.952	USD -160,685	75.28 Profit of 19,979 on sale
2025-04-08	SELL	-300	64.970	70.560	70.001	USD -21,000	75.48 Profit of 1,645 on sale
2025-04-07	SELL	-300	68.090	70.520	70.277	USD -21,083	75.57 Profit of 1,588 on sale
2025-04-04	SELL	-1,500	69.180	72.500	72.168	USD -108,252	75.64 Profit of 5,215 on sale
2025-04-01	BUY	2,597	72.000	75.650	75.285	USD 195,515	75.72
2025-03-31	SELL	-888	76.290	76.700	76.659	USD -68,073	75.71 Loss of -844 on sale
2025-03-21	BUY	4,857	79.920	81.190	81.063	USD 393,723	75.50
2025-03-14	SELL	-4,480	76.550	77.410	77.324	USD -346,412	75.34 Loss of -8,899 on sale
2025-03-07	SELL	-558	74.890	76.170	76.042	USD -42,431	75.43 Loss of -343 on sale
2025-03-04	SELL	-280	77.210	78.410	78.290	USD -21,921	75.37 Loss of -817 on sale
2025-02-25	BUY	560	77.500	81.670	81.253	USD 45,502	75.10
2025-02-19	SELL	-279	83.830	83.890	83.884	USD -23,404	74.58 Loss of -2,595 on sale
2025-02-13	BUY	837	78.670	79.690	79.588	USD 66,615	74.17
2025-02-12	BUY	279	79.600	80.280	80.212	USD 22,379	74.06
2025-02-11	BUY	1,116	79.890	80.010	79.998	USD 89,278	73.94
2024-12-30	SELL	-6,129	68.870	69.600	69.527	USD -426,131	72.36 Profit of 17,381 on sale
2024-11-18	SELL	-4,425	66.610	67.260	67.195	USD -297,338	70.94 Profit of 16,559 on sale
2024-11-08	SELL	-295	73.540	73.640	73.630	USD -21,721	70.81 Loss of -832 on sale
2024-10-21	SELL	-295	72.280	74.290	74.089	USD -21,856	0.00 Loss of -21,856 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of INSM

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	172,531	1,415	480,687	35.9%
2025-09-18	192,419	1,396	488,532	39.4%
2025-09-17	258,254	358	657,586	39.3%
2025-09-16	234,877	118	631,379	37.2%
2025-09-15	281,798	0	849,087	33.2%
2025-09-12	276,876	0	792,549	34.9%
2025-09-11	232,789	1,547	706,713	32.9%
2025-09-10	298,194	739	767,290	38.9%
2025-09-09	285,006	1	607,090	46.9%
2025-09-08	226,229	224	654,288	34.6%
2025-09-05	325,826	28	1,044,438	31.2%
2025-09-04	248,903	665	733,063	34.0%
2025-09-03	350,854	0	1,100,919	31.9%
2025-09-02	978,520	3,528	2,123,858	46.1%
2025-08-29	391,481	15	838,637	46.7%
2025-08-28	307,994	19,763	681,033	45.2%
2025-08-27	359,423	0	988,381	36.4%
2025-08-26	309,084	9	862,404	35.8%
2025-08-25	328,526	86	915,125	35.9%
2025-08-22	499,368	0	1,021,146	48.9%
2025-08-21	473,469	1,317	988,731	47.9%
2025-08-20	436,053	3,929	931,883	46.8%
2025-08-19	428,166	0	1,016,557	42.1%
2025-08-18	562,718	1,268	1,332,877	42.2%
2025-08-15	736,274	30	1,803,556	40.8%
2025-08-14	1,023,934	320	2,229,622	45.9%
2025-08-13	722,475	1	2,238,834	32.3%
2025-08-12	1,753,666	701	3,484,210	50.3%
2025-08-11	511,651	0	1,434,176	35.7%
2025-08-08	360,306	0	1,213,665	29.7%
2025-08-07	435,145	186	1,629,363	26.7%
2025-08-06	541,497	1,814	1,567,245	34.6%
2025-08-05	557,375	3,053	1,406,789	39.6%
2025-08-04	510,869	48	1,127,744	45.3%
2025-08-01	385,708	1,135	1,044,895	36.9%
2025-07-31	570,588	2,598	1,011,306	56.4%
2025-07-30	777,296	1,400	1,553,457	50.0%
2025-07-29	245,874	242	687,941	35.7%
2025-07-28	330,814	146	938,038	35.3%
2025-07-25	243,537	471	722,557	33.7%
2025-07-24	171,398	18	713,656	24.0%
2025-07-23	236,916	636	800,818	29.6%
2025-07-22	228,382	0	552,067	41.4%
2025-07-21	252,530	0	764,289	33.0%
2025-07-18	244,497	1,210	505,608	48.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE